The density of CD8+ cells obtained by this approach on our RCC TMA was comparable to the values that we earlier collected for clear cell RCC (306 ± 479; this study 430 ± 22) and papillary RCC (141 ± 149; this study 190 ± 45) in a study assessing the number of CD8+ cells across a broad range of different tumor entities (manuscript under revision, Cellular Oncology). The gene discussed is CD8A; the disease is renal cell adenocarcinoma.